Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Kura Oncology (KURA) EBT Margin (2024 - 2025)

Historic EBT Margin for Kura Oncology (KURA) over the last 2 years, with Q3 2025 value amounting to 357.19%.

  • Kura Oncology's EBT Margin fell 135620400.0% to 357.19% in Q3 2025 from the same period last year, while for Sep 2025 it was 431.5%, marking a year-over-year change of. This contributed to the annual value of 319.15% for FY2024, which is 101726600.0% down from last year.
  • Kura Oncology's EBT Margin amounted to 357.19% in Q3 2025, which was down 135620400.0% from 432.51% recorded in Q2 2025.
  • Kura Oncology's 5-year EBT Margin high stood at 13204.85% for Q3 2024, and its period low was 432.51% during Q2 2025.